Novavax COVID-19 Vaccine Omicron Subvariant Booster
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Novavax COVID-19 Vaccine Omicron Subvariant Booster, covering 2024-05-30 to 2024-05-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. [Phase 2, Phase 3]